Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 11 Prostatic Neoplasms 9 Uterine Neoplasms 2 Hyperthermia 2 Endometrial Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Rhabdomyosarcoma 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Locally Advanced Cervical Adenocarcinoma 1 Head and Neck Neoplasms 1 Genital Neoplasms, Female 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Clear Cell Adenocarcinoma 1 Directly Observed Therapy 1 Cervical Adenocarcinoma 1 Carcinoma, Renal Cell 1 Adenocarcinoma 1

Interventions

pembrolizumab 25 Cisplatin 17 Carboplatin 13 Radiotherapy 12 Cetuximab 9 Blood Specimen Collection 9 Docetaxel 8 Paclitaxel 7 Fluorouracil 7 Drug Therapy 7 toripalimab 6 tislelizumab 4 nimotuzumab 4 atezolizumab 4 Surveys and Questionnaires 4 Radiation 4 Chemoradiotherapy 4 fludarabine 3 Surgical Procedures, Operative 3 Standard of Care 3 Radiotherapy, Intensity-Modulated 3 Cyclophosphamide 3 Biopsy 3 130-nm albumin-bound paclitaxel 3 cemiplimab 2 avelumab 2 X-Rays 2 Tocopherols 2 Tiragolumab 2 Therapeutics 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Head and Neck Neoplasms × Brachytherapy × Clear all

NCT03238378 2018-06-08

HyBT-H&N

University of Erlangen-Nürnberg Medical School

Phase NA Recruiting

Hyperthermia, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡